BACKGROUND: The novel SARS-CoV-2 virus has caused a global pandemic of coronavirus disease 2019 (COVID-19). Although immunosuppressed individuals are thought to be at an increased risk of severe disease, little is known about their clinical presentation, disease course, or outcomes. METHODS: We report 15 kidney transplant recipients from the Columbia University kidney transplant program who required hospitalization for confirmed COVID-19, and describe their management, clinical course, and outcomes. RESULTS: Patients presented most often with a fever (87%) and/or cough (67%). Initial chest x-ray most commonly showed bilateral infiltrates, but 33% had no acute radiographic findings. Patients were managed with immunosuppression reduction and the addition of hydroxychloroquine and azithromycin. Although 27% of our patients needed mechanical ventilation, over half were discharged home by the end of follow-up. CONCLUSIONS: Kidney transplant recipients with COVID-19 have presentations that are similar to that of the general population. Our current treatment protocol appears to be associated with favorable outcomes, but longer follow-up of a larger cohort of patients is needed.
BACKGROUND: The novel SARS-CoV-2 virus has caused a global pandemic of coronavirus disease 2019 (COVID-19). Although immunosuppressed individuals are thought to be at an increased risk of severe disease, little is known about their clinical presentation, disease course, or outcomes. METHODS: We report 15 kidney transplant recipients from the Columbia University kidney transplant program who required hospitalization for confirmed COVID-19, and describe their management, clinical course, and outcomes. RESULTS:Patients presented most often with a fever (87%) and/or cough (67%). Initial chest x-ray most commonly showed bilateral infiltrates, but 33% had no acute radiographic findings. Patients were managed with immunosuppression reduction and the addition of hydroxychloroquine and azithromycin. Although 27% of our patients needed mechanical ventilation, over half were discharged home by the end of follow-up. CONCLUSIONS: Kidney transplant recipients with COVID-19 have presentations that are similar to that of the general population. Our current treatment protocol appears to be associated with favorable outcomes, but longer follow-up of a larger cohort of patients is needed.
Authors: Chung-Ming Chu; Leo L M Poon; Vincent C C Cheng; Kin-Sang Chan; Ivan F N Hung; Maureen M L Wong; Kwok-Hung Chan; Wah-Shing Leung; Bone S F Tang; Veronica L Chan; Woon-Leung Ng; Tiong-Chee Sim; Ping-Wing Ng; Kin-Ip Law; Doris M W Tse; Joseph S M Peiris; Kwok-Yung Yuen Journal: CMAJ Date: 2004-11-23 Impact factor: 8.262
Authors: Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai Journal: N Engl J Med Date: 2020-01-31 Impact factor: 91.245
Authors: Guoxin Mo; Xin Yuan; Yi Tao; Xiaohua Peng; Fu-Sheng Wang; Lixin Xie; Lokesh Sharma; Charles S Dela Cruz; Enqiang Qin Journal: Am J Respir Crit Care Med Date: 2020-05-01 Impact factor: 21.405
Authors: Elena Guillen; Gaston J Pineiro; Ignacio Revuelta; Diana Rodriguez; Marta Bodro; Asunción Moreno; Josep M Campistol; Fritz Diekmann; Pedro Ventura-Aguiar Journal: Am J Transplant Date: 2020-04-09 Impact factor: 9.369
Authors: Andrew S Bomback; Pietro A Canetta; Wooin Ahn; Syeda B Ahmad; Jai Radhakrishnan; Gerald B Appel Journal: Clin J Am Soc Nephrol Date: 2020-04-24 Impact factor: 8.237
Authors: Anthony M Valeri; Shelief Y Robbins-Juarez; Jacob S Stevens; Wooin Ahn; Maya K Rao; Jai Radhakrishnan; Ali G Gharavi; Sumit Mohan; S Ali Husain Journal: J Am Soc Nephrol Date: 2020-05-28 Impact factor: 10.121